Brolucizumab—early real-world experience: BREW study

被引：0
|
作者：
Ashish Sharma
Nilesh Kumar
Nikulaa Parachuri
Srinivas R. Sadda
Giulia Corradetti
Jeffrey Heier
Adam T. Chin
David Boyer
Pouya Dayani
Sruthi Arepalli
Peter Kaiser
机构：
[1] Lotus Eye Hospital and Institute,
[2] Doheny Eye Institute Los Angeles CA USA,undefined
[3] Department of Ophthalmology David Geffen School of Medicine,undefined
[4] UCLA,undefined
[5] Ophthalmic Consultants of Boston,undefined
[6] Tufts Medical Center,undefined
[7] Retina Vitreous Associates Medical Group,undefined
[8] Cole Eye Institute,undefined
[9] Cleveland Clinic,undefined
来源：
Eye | 2021年 / 35卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1045 / 1047
页数：2
相关论文
共 50 条
  • [1] Correction: Brolucizumab—early real-world experience: BREW study
    Ashish Sharma
    Nilesh Kumar
    Nikulaa Parachuri
    Srinivas R. Sadda
    Giulia Corradetti
    Jeffrey Heier
    Adam T. Chin
    David Boyer
    Pouya Dayani
    Sruthi Arepalli
    Peter Kaiser
    Eye, 2021, 35 (4) : 1286 - 1286
  • [2] Real-world experience of brolucizumab in nAMD
    Narnaware, Shilpi H.
    Bansal, Anju
    Bawankule, Prashant K.
    Raje, Dhananjay
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2024, 72 (SUPPL 1) : S27 - S32
  • [3] Brolucizumab-early real-world experience: BREW study (Jul, 10.1038/s41433-020-1111-x, 2020)
    Sharma, Ashish
    Kumar, Nilesh
    Parachuri, Nikulaa
    Sadda, Srinivas R.
    Corradetti, Giulia
    Heier, Jeffrey
    Chin, Adam T.
    Boyer, David
    Dayani, Pouya
    Arepalli, Sruthi
    Kaiser, Peter
    EYE, 2021, 35 (04) : 1286 - 1286
  • [4] Real-world efficacy and safety of brolucizumab
    Walter, Scott
    Saba, Nicholas
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [5] Real-World Experience With Brolucizumab 6 mg for Diabetic Macular Edema
    Braganca, Francisca
    Ferreira, Andre
    Leite, Joao
    Coelho, Joao
    Borges, Tania
    Caiado, Filipa
    Correia, Nuno
    Beirao, Joao
    Meneres, Pedro
    Pessoa, Bernardete
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [6] Real-World Experience with Brolucizumab in Wet Age-Related Macular Degeneration: The REBA Study
    Bilgic, Alper
    Kodjikian, Laurent
    March de Ribot, Francesc
    Vasavada, Vaishali
    Gonzalez-Cortes, Jesus H.
    Abukashabah, Amro
    Sudhalkar, Aditya
    Mathis, Thibaud
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (13)
  • [7] Real-world analysis of brolucizumab in neovascular AMD
    Rave, Vanessa
    Sharma, Kayshaliya
    Wagner, Alan
    Kapoor, Kapil
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [8] Brolucizumab in Neovascular Age-Related Macular Degeneration - Indian Real-World Experience: The BRAILLE Study
    Chakraborty, Debdulal
    Maiti, Aniruddha
    Sheth, Jay U.
    Boral, Subhendu
    Mondal, Soumen
    Nandi, Krishnendu
    Sinha, Tushar
    Das, Arnab
    CLINICAL OPHTHALMOLOGY, 2021, 15 : 3787 - 3795
  • [9] Therapy for AMD: real-world data on the safety of brolucizumab
    Bitzer, Michaela
    AUGENHEILKUNDE UP2DATE, 2023, 13 (01) : 5 - 6
  • [10] EARLY REAL-WORLD EXPERIENCE OF OCRELIZUMAB IN MS
    Harding, Katharine
    Ingram, Gillian
    Horton, Emma
    Owen, Helen
    Joseph, Fady
    Pearson, Owen
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (12): : E56 - E56
12345